Long noncoding RNA identification in lymphoma. (November 2017)

• Record Type: Journal Article
• Authors: Siyu, Gu; Linqing, Zou; Linling, Kong; Hong, Liu; Guoqi, Song; Cho, William C
• Is Part Of: Future oncology. Volume 13:Number 27(2017)
• Page Start: 2479
• Page End: 2487
• Publication Date: 2017-11
• Subjects: biomarkers -- diagnosis -- lncRNA -- lymphoma -- prognosis -- therapeutic targets; Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon-2017-0230
• Languages: English
• ISSNs: 1479-6694

Abstract

It has been found that long noncoding RNA (lncRNA) are abnormally expressed in lymphoma and play an important role in its pathogenesis. Through the detection and analysis of lncRNA, it was found that lncRNA could be used as an excellent biomarker for the diagnosis and prognosis of cancer. In lymphoma, abnormal lncRNA expression is associated with the patient's clinical characteristics, it can be used to determine the prognosis of the patient and serve as a therapeutic target in the disease.